Organism name | Tanacetum longifolium |
---|---|
Genus | Tanacetum |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Tanacetum |
---|---|
Linked NCBI taxonomy ID | 99105 |
Linked level | genus |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003672
![]() |
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00037436
![]() |
Ludartin
|
No. 227 | No. 38 |
![]() |
||||
C00033803
![]() |
Eicosanyl-trans-p-coumarate
|
No. 447 |
![]() |
|||||
C00021309
![]() |
alpha-Himachalene
|
No. 478 | No. 38 |
![]() |
||||
C00037113
![]() |
Epizonarene
/ (+)-Epizonarene |
No. 574 |
![]() |
|||||
C00034757
![]() |
(Z)-Nerolidol
/ cis-Nerolidol |
CHEMBL25424
CHEMBL508801 CHEMBL561014 CHEMBL1923157 |
3 / 3 / 1 | No. 726 | No. 38 |
![]() |
||
C00029422
![]() |
1-Octadecanol
/ Octadecan-1-ol |
CHEMBL24640
|
C009316
|
3 / 11 / 10 | No. 732 |
![]() |
||
C00030805
![]() |
1-Docosanol
/ n-Docosanol |
CHEMBL1200453
|
C529236
|
1 / 0 / 0 | No. 732 |
![]() |
||
C00021283
![]() |
Cyperene
|
No. 1454 |
![]() |
|||||
C00029970
![]() |
cis-alpha-Bergamotene
|
No. 1653 | No. 38 |
![]() |
||||
C00035857
![]() |
Octane
/ n-Octane |
CHEMBL134886
|
C026728
|
No. 1749 |
![]() |
|||
C00003046
![]() |
Geranyl acetate
/ trans-Geranyl acetate / Acetic acid geraniol ester |
CHEMBL1369384
|
5 / 3 / 4 | No. 2157 | No. 34 |
![]() |
||
C00035138
![]() |
Neryl acetate
|
CHEMBL1369384
|
5 / 3 / 4 | No. 2157 | No. 34 |
![]() |
||
C00037604
![]() |
p-Cymen-9-ol
|
No. 2172 | No. 35 |
![]() |
||||
C00029544
![]() |
4-Terpineol
/ Terpin-4-ol / Terpineol-4 / Terpinen-4-ol |
CHEMBL507795
|
C034019
|
1 / 3 / 0 | No. 2215 |
![]() |
||
C00000830
![]() |
cis-Sabinene hydrate
|
No. 3782 | No. 35 |
![]() |
||||
C00000821
![]() |
(+)-trans-Sabinene hydrate
|
No. 3782 | No. 35 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00003046 C00034757 C00035138 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003046 C00035138 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00003046 C00035138 | 3 / 4 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003046 C00035138 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003046 C00035138 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00034757 | 3 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003672 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003672 | 1 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00030805 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00029422 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00029422 | 11 / 10 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00034757 | 0 / 0 |
P00734 | Prothrombin | S1A | C00003672 | 4 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
P06746 | DNA polymerase beta | Enzyme | C00003672 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003672 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00003672 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003672 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003672 | 0 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00029422 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00029544 | 3 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 | 1 / 1 |
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#218800 | Crigler-najjar syndrome, type i |
P22310
|
#606785 | Crigler-najjar syndrome, type ii |
P22310
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#143500 | Gilbert syndrome |
P22310
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P00734
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|